Session 1: Smarter Solid Form & Pre-formulation Studies

Sorry, we couldn't find any posts. Please try a different search.

Session 2: Physical Property Based Crystallization Process Development

Examples of Particle Engineering to Improve Patient Outcomes and Product Manufacturing

Dr. Christopher Burcham, Eli Lilly and Company

Details

Crystal Habit Modifications and Spherical Crystallization Design in Solution

Prof. Junbo Gong, Tianjin University

Details

Challenges and Opportunities in Optimizing Mechanical Properties of Drugs by Incorporating Excipients

Prof. Calvin Changquan Sun, University of Minnesota

Details
Dr. Jian Wang (J-Star)

Bridging the Gap between Drug Substance and Drug Product Processing via Co-Processing

Dr. Jian Wang, CfPC/J-Star/Porton

Details

Session 3: Physical Property Based Crystallization Process Development

Kevin J Roberts

The Importance of Understanding and Characterising the Physical & Chemical Properties of APIs in the Digital Design of Drug Products

Prof. Kevin Roberts, University of Leeds

Details

Continuous Crystallization and Purification: The Role of Impurity Incorporation Mechanism in Non-Equilibrium Processes

Prof. Allan Myerson, MIT

Details

Co-Crystals Platform to Improve Physical Properties of Early Intermediates during API Manufacturing Process

Dr. Samir Kulkarni, Pfizer

Details

Correlation of Solubility with the Metastable Limit

Prof. Ken Morris, Long Island University

Details

Session 4: Topical Panel Discussions

Potentials and Technologies to Increase Success Rate of Polymorph Screening

Moderator: Dr. Alfred Lee, Merck

Details

Overcoming Industrial Challenges in Implementation of Crystallization Technologies

Moderator: Dr. Kevin Girard, Pfizer

Details

Realizing Regulatory Challenges in Applying Crystallization Technologies

Moderator: Dr. Christopher Burcham, Eli Lilly and Company

Details